COURTNEY LEDGERWOOD: Open Payments
NPI 1295564193 · VOORHEES, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$754 in 40 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $58 · 2025 $754
Food & beverage: $684Education: $70
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 7 | $153 |
| Lundbeck LLC | 5 | $91 |
| Exact Sciences Corporation | 3 | $69 |
| Novo Nordisk Inc | 4 | $63 |
| Axsome Therapeutics, Inc. | 3 | $52 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| ABBVIE INC. | 2 | $35 |
| Globus Medical, Inc. | 1 | $34 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $33 |
Products named: REXULTI, Veozah, The Cologuard Plus Collection Kit, Auvelity, VRAYLAR, Senza, SHINGRIX, XIFAXAN.
Industry payments across NJ — which companies pay providers there.
